Home › Press
Réduire la taille de la police Agrandir la taille de la police Imprimer la page

Cerba HealthCare S.A.S- 20/03/2017

Conditional notice of redemption.

Licensing agreement between Cerba and IntegraGen for the commercialization...- 08/03/2017

Licensing agreement between Cerba and IntegraGen for the commercialization of miR-31-3p tumor expression test in cancerology.

CERBA HEALTHCARE S.A.S. ANNOUNCES PRELIMINARY FINANCIAL RESULTS...- 23/02/2017

Cerba HealthCare S.A.S announces preliminary financial results for year end 2016 and expected redemption of existing notes.

The ambassador of Russia visits Laboratoire Ketterthill- 22/02/2017

iDTECT™ BLOOD test for precision diagnosis of infectious diseases- 13/02/2017

Diagnosis of infectious diseasesthe iDTECT™ BLOOD test available for clinical use in the precision Laboratoire CERBA and PATHOQUEST announce partnership making.

Haut de page

Contact. | Sitemap